Ireland· IE-PA-EU/1/07/396/004
Pergoveris (300 IU + 150 IU)/0.48 mL solution for injection in pre-filled pen
A gonadotropine, kombinationen product containing lutropin alfa + follitropin alfa, registered in Ireland by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Gonadotropine, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA30 (gonadotropine, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Gonadotropine, kombinationen · ATC G03GA30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Lutropin alfa + Follitropin alfa
- Manufacturer
- Merck Europe B.V.
- Country
- Ireland (IE)
- ATC code
- G03GA30
- ATC class
- Gonadotropine, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/07/396/004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gonadotropine, kombinationen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPERGOVERIS (300 UI + 150 UI)/0,48 ML SOLUCION INYECTABLE EN PLUMA PRECARGADAMerck Europe B.V.
- FinlandPergoverisParanova Oy
- CzechiaPERGOVERISMerck Europe B.V., Amsterdam
- United KingdomPergoveris 150unit/75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandPergoverisMerck Europe B.V.*
- PolandPergoverisMerck Europe B.V.
- CanadaPERGOVERISEMD SERONO, A DIVISION OF EMD INC., CANADA
- SwitzerlandPergoveris Pen 300 IE/150 IE/0.48 ml, Injektionslösung im FertigpenMerck (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pergoveris
- Liechtenstein · Pergoveris
- Norway · Pergoveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3818dd47-9cdf-4f6f-b1a4-211d56575caf GET /v1/drugs/3818dd47-9cdf-4f6f-b1a4-211d56575caf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"G03GA",
"G03GA30"
],
"strength": null,
"pa_number": "EU/1/07/396/004",
"substances": [
"Lutropin alfa",
"Follitropin alfa"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "08/05/2017",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about gonadotropine, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.